期刊文献+

Th17细胞相关因子在蕈样肉芽肿患者外周血中的表达和意义

Expression and significance of Th17 related cytokines in peripheral blood of patients with mycosis fungoides
下载PDF
导出
摘要 目的探讨辅助性T细胞17(Th17)细胞相关因子在蕈样肉芽肿患者外周血中的表达及意义。方法以湖北医药学院附属东风总医院(以下简称"我院")2010年1月~2014年10月确诊为蕈样肉芽肿的24例患者作为治疗组,以我院同期健康人群24例作为对照组。采用酶联免疫吸附测定(ELISA)法检测两组患者外周血中白介素17(IL-17)、白介素23(IL-23)和白介素16(IL-16)的表达水平,比较两组之间的差异。结果治疗组患者外周血中IL-17、IL-23和IL-6的表达水平分别为(210.14±33.47)、(244.11±39.88)、(24.54±7.66)ng/L,均高于对照组[(162.34±35.11)、(111.26±36.35)、(10.90±6.81)ng/L],差异均有统计学意义(均P〈0.05)。结论 Th17细胞相关因子在蕈样肉芽肿患者外周血中的过表达,提示其可能与蕈样肉芽肿发病有关。 Objective To explore the expression and significance of T helper 17 cell(Th17) related cytokines in peripheral blood of patients with mycosis fungoides. Methods 24 patients diagnosed as mycosis fungoides in Dongfeng General Hospital Affiliated to Hubei University of Medicine("our hospital" for short) from January 2010 to October2014 were taken as treatment group, 24 healthy persons at the same time in our hospital were taken as control group.Enzyme linked immunosorbent assay(ELISA) was used to analyze the expression of interleukin 17(IL-17), interleukin23(IL-23) and interleukin 6(IL-6) in peripheral blood of the two groups, and the differences between the two groups were compared. Results The levels of IL-17, IL-23 and IL-6 in peripheral blood of treatment group [(210.14±33.47),(244.11±39.88),(24.54±7.66) ng/L] were significantly higher than those of control group [(162.34±35.11),(111.26±36.35),(10.90±6.81) ng/L], the differences were all statistically significant(all P〈0.05). Conclusion The over-expression of Th17 related cytokines in peripheral blood of patients with mycosis fungoides indicates that it may be related to the genesis of mycosis fungoides.
出处 《中国医药导报》 CAS 2015年第23期101-103,共3页 China Medical Herald
基金 湖北省自然科学基金计划项目(2011CDC049) 湖北省十堰市科学技术研究与开发项目计划(2010st39)
关键词 蕈样肉芽肿 辅助性T细胞17 白介素17 白介素23 白介素6 Mycosis fungoides Th17 cell IL-17 IL-23 IL-6
  • 相关文献

参考文献14

  • 1Mease PJ. Inhibition of interleukin- 17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthri- tis and psoriasis [J]. Curr Opin Rheumatol,2015,27(2) : 127- 133.
  • 2Humme D, Nast A, Erdmann R, et al. Systematic review of combination therapies for mycosis fungoides [J]. Cancer Treat Rev, 2014,40 (8) : 927-933.
  • 3Moraes FY, Carvalho HA, Hanna SA, et al. Literature re- view of clinical results of total skin electron irradiation (TSEBT)of mycosis fungoides in adults [J]. Rep Pract On- col Radiother,2014,19(2) :92-98.
  • 4Olek-Hrab K,Silny W. Diagnostics in mycosis fungoides and Sezary syndrome [J]. Rep Pract Oncol Radiother,2014, 19(2) :72-76.
  • 5Vollmer RT. A review of survival in mycosis fungoides [J]. Am J Clin Pathol, 2014,141 (5) : 706-711.
  • 6Gaffen SL,Jain R,Garg AV,et al. The IL-23-IL-17 im- mune axis :from mechanisms to therapeutic testing [J]. Nat Rev Immunol, 2014, 14(9) : 585-600.
  • 7Blake SJ,Teng MW. Role of IL-17 and IL-22 in autoim- munity and cancer [J]. Actas Dermosifiliogr,2014,105(Sup- pl 1) :41-50.
  • 8Shabgah AG,Fattahi E,Shahneh FZ. Interleukin-17 in hu- man inflammatory diseases [J]. Postepy Dermatol Alergol, 2014,31(4) :256-261.
  • 9Zambrano-Zaragoza JF, Romo-Martinez E J, Duran-Ave- lar MJ,et al. Th17 ceils in autoimmune and infectious diseases [J]. Int J Inflam, 2014, (2014) : 651503.
  • 10Lin S,Yang X,Liang D,et al. Treg cells:a potential regu- lator for IL-22 expression [J]. Int J Clin Exp Pathol,2014, 7(2) :474-480.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部